The best Bull and Bear pitches based on recency and number of recommendations.
As of 10/19/11, Neoprobe's New Drug Application (NDA) for Lymphoseek® (tilmanocept) has been accepted for review by the FDA.
Extremely overvalued trash stock.
Read the most recent pitches from players about NAVB.
Recs
BooDog2
(< 20)
Submitted: 5/6/2015 12:12:01 PM :
Start Price:
$1.25
NASDAQ OTC:NAVB Score:
-214.25
$NAVB basing near the $ once again. New management and great potential with their new platform under Goldberg. Gonzalez as the new CEO pushing the marketing potential for Lymphoseek. $2+ short term potential imo.
Recs
FlyinBlind
(54.36)
Submitted: 3/28/2015 9:32:05 AM :
Start Price:
$1.68
NASDAQ OTC:NAVB Score:
+216.57
NAVB will outperform the market over the next 5 years, but due to its burn rate on R&D and G&A, it will go through a number of rounds of financing that will dilute out shareholders. This stock will excel, but there are stocks that are closer to monetizing shareholdeer value
Recs
minmartar
(< 20)
Submitted: 9/19/2014 1:00:18 AM :
Start Price:
$1.44
NASDAQ OTC:NAVB Score:
-221.99
No competition.
Extremely undervalued.
Find the members with the highest scoring picks in NAVB.
Europecv (26.49) Score: +393.50
The Score Leader is the player with the highest score across all their picks in NAVB.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| capostatus | 28.06 | 10/12/2010 |
|
5Y | $1.65 | -96.72% | +292.38% | +389.11 | 0 Comment | |
| stockjock11 | 91.63 | 3/26/2010 |
|
NS | $1.72 | -96.85% | +288.33% | +385.19 | 1 Comment | |
| Europecv | 26.49 | 11/23/2010 |
|
5Y | $1.82 | -97.03% | +284.72% | +381.75 | 0 Comment | |
| Caboverde | 26.84 | 10/22/2010 |
|
5Y | $1.62 | -96.66% | +284.88% | +381.54 | 0 Comment | |
| TheChozen1 | < 20 | 10/22/2010 |
|
5Y | $1.60 | -96.62% | +284.72% | +381.34 | 0 Comment | |
| SuperNova007 | 97.92 | 4/9/2010 |
|
5Y | $1.79 | -96.98% | +282.23% | +379.21 | 0 Comment | |
| BuffettJunior1 | 99.73 | 10/17/2011 |
|
5Y | $3.02 | -98.21% | +275.73% | +373.94 | 1 Comment | |
| walt393 | 99.96 | 12/15/2011 |
|
5Y | $2.46 | -97.80% | +269.77% | +367.57 | 0 Comment | |
| williamstep | 97.73 | 6/3/2011 |
|
5Y | $4.70 | -98.85% | +249.54% | +348.39 | 0 Comment | |
| jrokket731 | 38.01 | 2/25/2011 |
|
5Y | $4.60 | -98.82% | +244.38% | +343.21 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
